Veracyte, Inc. (VCYT) Live Share Price, Invest From India

Veracyte, Inc. Stock Performance

as on January 31, 2026 at 2:29 am IST

Day's Low
Day's High
$37.33
Day's Price Range
$38.44
$38.06
1.92%
Downside
1.00%
Upside
52 Week's Low
52 Week's High
$22.61
52-Week Price Range
$50.71
$38.06
40.59%
Downside
33.24%
Upside

Veracyte, Inc. share price movements today

Previous Close: $38.74
Open: $38.37
Volume: 704.7K
Day's Low - High: $37.33 - $38.44
52 Week Low - High: $22.61 - $50.71

Veracyte, Inc. Historical Returns

1 Month Return: -9.55 %
3 Month Return: + 5.54 %
1 Year Return: -16.27 %
3 Year Return: + 51.53 %
5 Year Return: -32.84 %

Veracyte, Inc. Stock Fundamentals & Key Indicators

Check Veracyte, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.1B

EPS (TTM)

1.6602

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.26%

PE Ratio (TTM)

107.57

Industry PE ratio

5.33235294117647

PEG Ratio

EBITDA

73.7M

Revenue (TTM)

495.1M

Profit Margin

6.12%

Return On Equity TTM

2.49%

Veracyte, Inc. Stock Valuation

Track how Veracyte, Inc. P/E has moved over time to understand its valuation trends.

Veracyte, Inc. in the last 5 years

Overview
Trends

Lowest (-187.55x)

September 30, 2024

Industry (5.33x)

January 31, 2026

Today (107.57x)

January 31, 2026

Highest (63.11x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: 107.57x

Veracyte, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Veracyte, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Veracyte, Inc.	BUY	$3.1B	-32.84%	107.57	6.12%
Idexx Laboratories, Inc.	BUY	$55.8B	40.06%	55.25	24.65%
Thermo Fisher Scientific, Inc.	BUY	$235.4B	13.52%	36.24	15.02%
Iqvia Holdings Inc.	BUY	$41.0B	29.44%	33.11	8.07%
Agilent Technologies Inc.	BUY	$38.5B	11.38%	29.75	18.75%

See all

Stock Returns calculator for Veracyte, Inc. Stock including INR - Dollar returns

The Veracyte, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Veracyte, Inc. investment value today

Current value as on today

₹89,846

Returns

₹10,154

(-10.15%)

Returns from Veracyte, Inc. Stock

₹16,315 (-16.31%)

Dollar Returns*

₹6,161 (+6.16%)

Analyst Recommendation on Veracyte, Inc. Stock

Based on 15 analysts

BUY

73.33%

Buy

20.00%

Hold

6.67%

Sell

Based on 15 analysts, 73.33% of analysts recommend a 'BUY' rating for Veracyte, Inc.. Average target price of $47.67

Veracyte, Inc. Share Price Target

Get share price movements and forecasts by analysts on Veracyte, Inc..

What analysts predicted

20.16%UPSIDE

Target Price

$47.67

Current Price

$38.06

Analyzed by

15 Analysts

Target

$47.67

Veracyte, Inc. target price $47.67, a slight upside of 20.16% compared to current price of $38.06. According to 15 analysts rating.

Veracyte, Inc. Stock’s Investor Sentiment and Interest

Search interest for Veracyte, Inc. Stock has decreased by -16% in the last 30 days, reflecting a downward trend in search activity.

Time period: January 1, 2026 to January 31, 2026

Change:-16% versus previous 30 day period

Veracyte, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	90	90	98	96	114	115	118	114	130	131
Gross Profit	55	62	68	62	77	79	78	79	89	91
Operating Income	-8	-31	-35	-4	4	12	4	2	-5	22
EBITDA	-1	-22	-24	1	13	22	9	6	6	24
Interest Expense	0	0	0	-	0	0	-	-	-	-
Depreciation	6	7	6	5	5	5	6	5	5	5
Income Before Tax	-8	-29	-30	-1	7	16	3	7	1	18
Income Tax Expense	0	0	-2	0	1	1	-1	0	2	0
Net Income	-8	-29	-28	-1	5	15	5	7	0	19
Net Profit Margin	-9.30%	-32.87%	-28.81%	-1.92%	5.01%	13.08%	4.31%	6.16%	-0.75%	14.51%

Veracyte, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	49	65	71	92	120	117	219	296	361	445
Gross Profit	28	39	43	58	83	76	145	194	248	298
Operating Income	-33	-28	-26	-22	-15	-35	-81	-41	-85	16
EBITDA	-32	-25	-23	-17	-7	-26	-60	-6	-49	49
Interest Expense	0	2	4	1	0	0	0	0	0	0
Depreciation	-	-	3	3	4	7	19	25	27	23
Income Before Tax	-33	-31	-31	-22	-12	-34	-81	-36	-76	25
Income Tax Expense	0	2	5	1	3	0	-6	0	-2	1
Net Income	-33	-31	-31	-22	-12	-34	-75	-36	-74	24
Net Profit Margin	-68.08%	-48.18%	-43.09%	-25.00%	-10.47%	-29.71%	-34.42%	-12.33%	-20.61%	5.41%

Veracyte, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	-29	-28	-1	5	15	5	7	0	19
Operating Cash Flow	14	15	-8	29	29	24	5	33	44
Investing Cash Flow	-2	-2	2	-2	-2	-54	-51	0	48
Financing Cash Flow	0	0	0	0	10	-4	-6	0	2
Change in Cash	11	13	-7	26	38	-34	-52	33	96

Veracyte, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-31	-31	-22	-12	-34	-75	-36	-74	24
Operating Cash Flow	-27	-23	-13	-3	-9	-31	7	44	75
Investing Cash Flow	-4	-1	-1	-42	-3	-739	-29	15	-56
Financing Cash Flow	52	0	59	127	203	596	3	2	4
Change in Cash	20	-25	44	81	190	-176	-18	62	23

Global Institutional Holdings in Veracyte, Inc.

Funds	Holdings
Amova Asset Management Americas, Inc	2.09%
Goldman Sachs Group Inc	1.97%
Squarepoint Ops LLC	1.14%
BlackRock Inc	9.82%
Artisan Partners Limited Partnership	8.04%

See all

Veracyte, Inc. News & Key Events

Insights on Veracyte, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -980.0K → 19.13M (in $), with an average increase of 105.1% per quarter
POSITIVE IMPACT
Best in 3 Years
In the last 3 years, VCYT has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Price Rise
In the last 6 months, VCYT stock has moved up by 62.0%
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 114.47M → 131.87M (in $), with an average increase of 6.7% per quarter
NO EFFECT
Against Peers
In the last 1 year, Idexx Laboratories, Inc. has given 58.9% return, outperforming this stock by 75.2%

About Veracyte, Inc.

veracyte is a pioneering genomic diagnostics company. our tests are dramatically improving clinical outcomes for patients by resolving inconclusive results from traditional diagnostic methods. we ask the right questions to resolve ambiguity and bring assurance to light, rendering tens of thousands of costly and unnecessary surgeries truly unnecessary. we are giving patients a clearer path forward. through scientific rigor we employ the best tools, best science and best minds to create tests that enable a more accurate diagnosis without the need for risky, costly and often unnecessary surgery. veracyte consistently brings to bear evidence that is unprecedented in genomic tests, thereby changing today's clinical practice standards. we are making a difference in the lives of physicians and patients. we are doing something real. .

Organisation	Veracyte, Inc.
Headquarters	6000 Shoreline Court, South San Francisco, CA, United States, 94080
Industry	Health Technology
CEO	Mr. Marc A. Stapley
E-voting on shares	Click here to vote

Key Management of Veracyte, Inc.

Name	Title
Ms. Annie McGuire	Executive VP, General Counsel & Chief People Officer
Dr. Keith Gligorich Ph.D.	Senior Vice President of Global Operations
Mr. Jonathan Wygant	VP & Chief Accounting Officer
Mr. Steven French	Senior VP & Chief Information Officer
Ms. Corinne Danan	Senior Vice President
Dr. Phillip G. Febbo M.D.	Chief Scientific & Medical Officer
Ms. Rebecca Chambers	Executive VP & CFO
Dr. John Leite Ph.D.	Global Chief Commercial Officer
Ms. Karen Possemato	Senior Vice President of Corporate Marketing, Communications & Commercial Operations
Mr. Marc A. Stapley	CEO & Director

FAQs

What is Veracyte, Inc. share price today?

Veracyte, Inc. share price today is $38.06 as on January 31, 2026 at 2:29 am IST at the close of the market. Veracyte, Inc. share today touched a day high of $38.44 and a low of $37.33.

What is the 52 week high and 52 week low for Veracyte, Inc. share?

Veracyte, Inc. share touched a 52 week high of $50.71 on November 25, 2025 and a 52 week low of $22.61 on July 18, 2025. Veracyte, Inc. stock price today i.e. January 31, 2026 at 2:29 am IST is closed at $38.06,which is 24.95% down from its 52 week high and 68.33% up from its 52 week low.

What is Veracyte, Inc.'s market capitalisation today?

Veracyte, Inc. market capitalisation is $0.00T as on January 31, 2026 at 2:29 am IST.

How to invest in Veracyte, Inc. Stock (VCYT) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Veracyte, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Veracyte, Inc. Shares that will get you 0.0394 shares as per Veracyte, Inc. share price of $38.06 per share as on January 31, 2026 at 2:29 am IST.

What is the minimum amount required to buy Veracyte, Inc. Stock (VCYT) from India?

Indian investors can start investing in Veracyte, Inc. (VCYT) shares with as little as ₹91.906 or $1 (as of January 31, 2026 at 12:40 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹919.06 in Veracyte, Inc. stock (as per the Rupee-Dollar exchange rate as on January 31, 2026 at 12:40 pm IST). Based on Veracyte, Inc. share’s latest price of $38.06 as on January 31, 2026 at 2:29 am IST, you will get 0.2627 shares of Veracyte, Inc.. Learn more about fractional shares .

What are the returns that Veracyte, Inc. has given to Indian investors in the last 5 years?

Veracyte, Inc. stock has given -32.84% share price returns and 25.1% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?